Previous Close | 35.99 |
Open | 36.03 |
Bid | 33.66 x 1100 |
Ask | 37.80 x 1100 |
Day's Range | 35.99 - 36.59 |
52 Week Range | 33.20 - 39.74 |
Volume | |
Avg. Volume | 3,695,600 |
Market Cap | 75.016B |
Beta (5Y Monthly) | 0.29 |
PE Ratio (TTM) | 9.78 |
EPS (TTM) | 3.74 |
Earnings Date | N/A |
Forward Dividend & Yield | 1.40 (3.84%) |
Ex-Dividend Date | Nov 16, 2023 |
1y Target Est | 39.88 |
Subscribe to Yahoo Finance Plus to view Fair Value for GSK
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates are expected drive the stock in the future quarters.
This quote has been attributed both to Mark Twain and Ambrose Bierce, and it may not have been uttered or written by either. Here are three foreign companies to consider for your portfolio. If you're familiar with and hopeful about fintech companies, such as PayPal, get to know Adyen (OTC: ADYE.Y) (OTC: ADYY.F).